ORAL 5-FLUOROURACIL IN PSORIASIS - PHARMACOKINETIC-PHARMACODYNAMIC RELATIONSHIPS

被引：12

作者：

ABERNETHY, DR

ALPER, JC

WIEMANN, MC

MCDONALD, CJ

CALABRESI, P

机构：

[1] BROWN UNIV,ROGER WILLIAMS GEN HOSP,DEPT MED,DIV DERMATOL,PROVIDENCE,RI 02908

[2] BROWN UNIV,ROGER WILLIAMS GEN HOSP,DEPT MED,DIV CLIN ONCOL,PROVIDENCE,RI 02908

[3] ROGER WILLIAMS GEN HOSP,CTR CANC,PROVIDENCE,RI 02908

来源：

PHARMACOLOGY | 1989年 / 39卷 / 02期

关键词：

D O I：

10.1159/000138581

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：78 / 88

页数：11

相关论文

共 30 条

[1] ALMERSJO OE, 1980, ACTA PHARMACOL TOX, V46, P329
[2] ALPER JC, 1984, CLIN RES, V32, pA254
[3] RATIONALLY DESIGNED COMBINATION CHEMOTHERAPY FOR THE TREATMENT OF PATIENTS WITH RECALCITRANT PSORIASIS
ALPER, JC
WIEMANN, MC
RUECKL, FS
MCDONALD, CJ
CALABRESI, P
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1985, 13 (04) : 567 - 577
[4] AU JLS, 1983, J PHARMACOL EXP THER, V227, P174
[5] AUBERT C, 1981, B CANCER, V68, P343
[6] CHRISTOPHERS E, 1987, DERMATOLOGY GENERAL, P486
[7] FLUOROURACIL THERAPY IN PATIENTS WITH CARCINOMA OF LARGE BOWEL - PHARMACOKINETIC COMPARISON OF VARIOUS RATES AND ROUTES OF ADMINISTRATION
CHRISTOPHIDIS, N
VAJDA, FJE
LUCAS, I
DRUMMER, O
MOON, WJ
LOUIS, WJ
[J]. CLINICAL PHARMACOKINETICS, 1978, 3 (04) : 330 - 336
[8] COHEN JL, 1974, CANCER CHEMOTH REP 1, V58, P723
[9] NON-LINEAR PHARMACOKINETIC MODELS FOR 5-FLUOROURACIL IN MAN - INTRAVENOUS AND INTRAPERITONEAL ROUTES
COLLINS, JM
DEDRICK, RL
KING, FG
SPEYER, JL
MYERS, CE
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 28 (02) : 235 - 246
[10] NONLINEAR PHARMACOKINETICS OF 5-FLUOROURACIL AS DESCRIBED BY INVIVO BEHAVIOR OF 5,6 DIHYDRO-5-FLUOROURACIL
DEBRUIJN, EA
REMEYER, L
TJADEN, UR
ERKELENS, C
DEBRAUW, LM
VANDEVELDE, CJH
[J]. BIOCHEMICAL PHARMACOLOGY, 1986, 35 (15) : 2461 - 2465